Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.36)
# 3,240
Out of 4,940 analysts
53
Total ratings
48.48%
Success rate
-6.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $192.50 | -4.42% | 5 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Overweight | $330 → $350 | $304.84 | +14.81% | 5 | Aug 8, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $147 → $142 | $131.36 | +8.10% | 6 | Jul 18, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $8.89 | +124.97% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $10.12 | +710.68% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $115.95 | +113.89% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $471.85 | -28.16% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.69 | +117.52% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.55 | +1,641.94% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $100.02 | +10.98% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $77.85 | +84.65% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $87.02 | -35.65% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $84.04 | -11.95% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $78.16 | -1.91% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $10.90 | +725.69% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $59.43 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $192.50
Upside: -4.42%
Insulet
Aug 8, 2025
Maintains: Overweight
Price Target: $330 → $350
Current: $304.84
Upside: +14.81%
Abbott Laboratories
Jul 18, 2025
Maintains: Overweight
Price Target: $147 → $142
Current: $131.36
Upside: +8.10%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $8.89
Upside: +124.97%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $10.12
Upside: +710.68%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $115.95
Upside: +113.89%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $471.85
Upside: -28.16%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.69
Upside: +117.52%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.55
Upside: +1,641.94%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $100.02
Upside: +10.98%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $77.85
Upside: +84.65%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $87.02
Upside: -35.65%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $84.04
Upside: -11.95%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $78.16
Upside: -1.91%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $10.90
Upside: +725.69%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $59.43
Upside: -